The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Microalbuminuria as an Early Marker for Cardiovascular Disease
Abstract
Excretion of albumin in the urine is highly variable, ranging from nondetectable quantities to milligrams of albumin and even grams of albumin. Microalbuminuria is defined as low levels of urinary albumin excretion of 30 to 300 mg/d. Microalbuminuria is highly prevalent; in hypertensive and diabetic populations, its prevalence varies from 10 to 40%. It is interesting that microalbuminuria also is found frequently in seemingly healthy individuals (5 to 7%). The variable excretion of albumin in the urine is related to the risk for the individual to develop cardiovascular (CV) disease: Absence or very low levels of albuminuria is associated with low CV risk, whereas the CV risk increases markedly with increasing amount of albumin in the urine (even within the now considered normal range). The predictive power of urinary albumin levels for CV risk is independent of other CV risk factors and not only is present in individual with diabetes and/or hypertension but also in healthy individuals. Treatments that lower albuminuria are associated with CV protection, as demonstrated in randomized, controlled trials of patients with diabetes as well as in patients with hypertension. There is preliminary evidence that albuminuria lowering is CV protective in healthy individuals with an elevated albumin excretion rate. Differences between individuals in their level of albumin excretion are already observed at a very early age (just after birth). In fact, the interindividual variability seems to be relatively constant in the first 5 decades of life, indicating that microalbuminuria is not necessarily a consequence of vascular damage at later age. Higher levels of urinary albumin seem to reflect the ordinary interindividual variability in (renal and systemic) endothelial function. Experimental data show that between strains and even within strains, rats at young age show a remarkable difference in individual endothelial function, and this is strongly related to the susceptibility of that rat to organ damage. In conclusion, albuminuria seems to be a sensitive marker very early in life for the susceptibility of an individual to CV disease. It therefore may be an ideal target for early primary prevention using CV-protective therapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Self-citationGerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Self-citationAlbuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
Ärnlöv, J., Evans, J. C., Meigs, J. B., Wang, T. J., Fox, C. S., Levy, D., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.538132 · Cited by 736
Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., & Jensen, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000133312.96477.48 · Cited by 693
Hillege, H. L., Janssen, W. M. T., Bak, A. A. A., Diercks, G. F. H., Grobbee, D. E., Crijns, H. J. G. M., Van Gilst, W. H., De Zeeuw, D., De Jong, P. E., & FOR THE PREVEND STUDY GROUP (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00833.x · Cited by 629
Self-citationDinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340025002 · Cited by 574
Wachtell, K., Ibsen, H., Olsen, M. H., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlf, B., Devereux, R. B., Beevers, G., de Faire, U., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00008 · Cited by 557
Parving, H.-H., Lewis, J. B., Ravid, M., Remuzzi, G., & Hunsicker, L. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000377 · Cited by 527
Self-citationEffects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Asselbergs, F. W., Diercks, G. F. H., Hillege, H. L., van Boven, A. J., Janssen, W. M. T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., & van Gilst, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000146378.65439.7a · Cited by 523
Self-citationUrinary Albumin Excretion: An Independent Predictor of Ischemic Heart Disease
Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 437
Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer, C. D. A., & Smulders, Y. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121288 · Cited by 428
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Borch-Johnsen, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.898 · Cited by 425
Lindberg, J. S., Culleton, B., Wong, G., Borah, M. F., Clark, R. V., Shapiro, W. B., Roger, S. D., Husserl, F. E., Klassen, P. S., Guo, M. D., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060512 · Cited by 413
INCREASED URINARY ALBUMIN-EXCRETION RATE IN BENIGN ESSENTIAL HYPERTENSION
Parving, H.-H., Mogensen, C. E., Jensen, H. Æ., & Evrin, P.-E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91002-2 · Cited by 409
Self-citationIs glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
Remuzzi, G., & Bertani, T. (1990) · Kidney International · doi:10.1038/ki.1990.217 · Cited by 397
Leeson, C. P. M., Kattenhorn, M., Morley, R., Lucas, A., & Deanfield, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.9.1264 · Cited by 379
The prognostic significance of proteinuria: The Framingham study
Kannel, W. B., Stampfer, M. J., Castelli, W. P., & Verter, J. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90763-4 · Cited by 377
Bigazzi, R., Bianchi, S., Baldari, D., & Campese, V. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816090-00014 · Cited by 331
Ozaki, T., Nishina, H., Hanson, M. A., & Poston, L. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0141m.x · Cited by 321
The epidemiology of chronic kidney disease
Atkins, R. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09403.x · Cited by 320
Romundstad, S., Holmen, J., Kvenild, K., Hallan, H., & Ellekjær, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00742-x · Cited by 270
Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives
de Jong, P. E., & Curhan, G. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010097 · Cited by 218
Stehouwer, C. D. A., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., & Bouter, L. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09211.x · Cited by 211
Feldt-Rasmussen, B. (1986) · Diabetologia · doi:10.1007/bf00452063 · Cited by 209
Yuyun, M. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh008 · Cited by 192
Gambaro, G., Kinalska, I., Oksa, A., Pont’uch, P., Hertlová, M., Olsovsky, J., Manitius, J., Fedele, D., Czekalski, S., Perusicová, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014254.87188.e5 · Cited by 192
Tapp, R. J., Shaw, J. E., Zimmet, P. Z., Balkau, B., Chadban, S. J., Tonkin, A. M., Welborn, T. A., & Atkins, R. C. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01079-0 · Cited by 186
Tonolo, G., Ciccarese, M., Brizzi, P., Puddu, L., Secchi, G., Calvia, P., Atzeni, M. M., Melis, M. G., & Maioli, M. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1891 · Cited by 168
Cross-Talk between the Kidney and the Cardiovascular System
Amann, K., Wanner, C., & Ritz, E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030204 · Cited by 160
Wachtell, K., Palmieri, V., Olsen, M. H., Bella, J. N., Aalto, T., Dahlöf, B., Gerdts, E., Wright, J. T., Papademetriou, V., Mogensen, C. E., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119895 · Cited by 142
Brantsma, A. H., Bakker, S. J. L., Hillege, H. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., & the PREVEND Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2525 · Cited by 141
Brantsma, A. H., Bakker, S. J. L., de Zeeuw, D., de Jong, P. E., & Gansevoort, R. T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111153 · Cited by 128
Verhave, J. C., Hillege, H. L., Burgerhof, J. G. M., Navis, G. J., de Zeeuw, D., & de Jong, P. E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060573.77611.73 · Cited by 122
Zenere, M. B., Arcaro, G., Saggiani, F., Rossi, L. C., Muggeo, M., & Lechi, A. (1995) · Diabetes Care · doi:10.2337/diacare.18.7.975 · Cited by 109
Glomerular Number and Function Are Influenced by Spontaneous and Induced Low Birth Weight in Rats
Schreuder, M. F., Nyengaard, J. R., Fodor, M., van Wijk, J. A. E., & de Waal, H. A. D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100875 · Cited by 107
Microalbuminuria in Type 2 Diabetics: An Important, Overlooked Cardiovascular Risk Factor
Weir, M. R. (2004) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.02524.x · Cited by 91
Nakamura, T., Ushiyama, C., Hirokawa, K., Osada, S., Shimada, N., & Koide, H. (2001) · American Journal of Nephrology · doi:10.1159/000046648 · Cited by 86
Yuyun, M. F., Dinneen, S. F., Edwards, O. M., Wood, E., & Wareham, N. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00940.x · Cited by 65
Gschwend, S., Buikema, H., Navis, G. J., Henning, R. H., de Zeeuw, D., & van Dokkum, R. P. E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000036865.22253.d4 · Cited by 58
Self-citationIbsen, H., Wachtell, K., Olsen, M. H., Borch‐Johnsen, K., Lindholm, L. H., Mogensen, C. E., & Dahlöf, B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09214.x · Cited by 53
Diercks, G. F. H., Stroes, E. S. G., Boven, A. J. V., van Roon, A. M., Hillege, H. L., de Jong, P. E., Smit, A. J., Gans, R. O. B., Crijns, H. J. G. M., Rabelink, T. J., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00748-1 · Cited by 43
Genetics of progressive renal failure in diabetic kidney disease
Liu, Y., & Freedman, B. I. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09917.x · Cited by 22
Cited by
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Metadata
- Authors
- de Zeeuw, D., Parving, H.-H., & Henning, R. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-08
- Volume
- 17
- Issue
- 8
- Pages
- 2100-2105
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2156101232
- Cited by
- 399
- References
- 48
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.